Dutch government embarrassed over Rx drug seizure

16 February 2009

The Netherlands' government has been embarrassed by the confiscation and eventual return of 500kg of the active ingredient for US drug major  Merck & Co's cardiovascular drug Cozaar (losartan), which was copied by  Indian generic manufacturer Dr Reddy's (Marketletter February 16). The  product was seized on the basis of an intellectual property rights  violation, despite the drug not enjoying patent protection in India or  Brazil, the countries of origin and destination, respectively, of the  shipment.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight